There is a good chance LifeStance Health Group Inc. (LFST) will undergo another restructuring.

The price of LifeStance Health Group Inc. (NASDAQ: LFST) closed at $5.21 in the last session, up 2.96% from day before closing price of $5.06. In other words, the price has increased by $+0.15 from its previous closing price. On the day, 512985 shares were traded. LFST stock price reached its highest trading level at $5.36 during the session, while it also had its lowest trading level at $4.95.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…



We take a closer look at LFST’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.20 and its Current Ratio is at 2.20. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.14.

Upgrades & Downgrades

UBS Downgraded its Buy to Neutral on March 17, 2022, whereas the target price for the stock was revised from $19 to $10.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 07 when Gouk Warren sold 15,106 shares for $7.20 per share. The transaction valued at 108,763 led to the insider holds 5,967,991 shares of the business.

Gouk Warren sold 15,106 shares of LFST for $113,144 on Oct 31. The Chief Administrative Officer now owns 5,983,097 shares after completing the transaction at $7.49 per share. On Oct 24, another insider, Gouk Warren, who serves as the Chief Administrative Officer of the company, sold 15,106 shares for $7.06 each. As a result, the insider received 106,648 and left with 5,998,203 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 2.32 while its Price-to-Book (P/B) ratio in mrq is 1.22.

Stock Price History:

Over the past 52 weeks, LFST has reached a high of $11.25, while it has fallen to a 52-week low of $4.22. The 50-Day Moving Average of the stock is 5.15, while the 200-Day Moving Average is calculated to be 6.78.

Shares Statistics:

According to the various share statistics, LFST traded on average about 525.03K shares per day over the past 3-months and 463.56k shares per day over the past 10 days. A total of 357.52M shares are outstanding, with a floating share count of 317.91M. Insiders hold about 3.10% of the company’s shares, while institutions hold 82.30% stake in the company. Shares short for LFST as of Oct 13, 2022 were 9.98M with a Short Ratio of 9.37M, compared to 9.28M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 2.65% and a Short% of Float of 13.58%.

Earnings Estimates

The company has 6 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.14 for the current quarter, with a high estimate of -$0.1 and a low estimate of -$0.18, while EPS last year was -$0.35. The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.08 and low estimates of -$0.18.

Analysts are recommending an EPS of between -$0.55 and -$0.74 for the fiscal current year, implying an average EPS of -$0.63. EPS for the following year is -$0.19, with 5 analysts recommending between -$0.1 and -$0.33.

Revenue Estimates

According to 6 analysts, the current quarter’s revenue is expected to be $219.65M. It ranges from a high estimate of $223.48M to a low estimate of $218.2M. As of the current estimate, LifeStance Health Group Inc.’s year-ago sales were $171.36M, an estimated increase of 28.20% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $236.16M, an increase of 24.30% less than the figure of $28.20% in the same quarter last year. There is a high estimate of $238.67M for the next quarter, whereas the lowest estimate is $233M.

A total of 7 analysts have provided revenue estimates for LFST’s current fiscal year. The highest revenue estimate was $874.14M, while the lowest revenue estimate was $865M, resulting in an average revenue estimate of $868.13M. In the same quarter a year ago, actual revenue was $667.51M, up 30.10% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $1.08B in the next fiscal year. The high estimate is $1.14B and the low estimate is $1.05B. The average revenue growth estimate for next year is up 24.90% from the average revenue estimate for this year.